Lise Bech Jellesmark Thorsen

VIP, Clinical Associate Professor

Aarhus University

Denmark

Research Interests

Explore related searches

Professors in Medical Imaging

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Lise Bech Jellesmark Thorsen is a Clinical Associate Professor at Aarhus University, Denmark. Her research areas include radiation therapy outcomes in soft tissue sarcoma and breast cancer, tumor-infiltrating lymphocytes, and the impact of coronary artery calcifications in high-risk breast cancer patients. She has contributed significantly to studies on the clinical utility of circulating human papillomavirus and the quality of oncological care during the COVID-19 pandemic.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Collaborators (6)

Robert Zachariae

Professor

Aarhus Universitet Business and Social Sciences

DENMARK

View details

Signe Borgquist

Aarhus University

DENMARK

View details

Thomas Baad-Hansen

Aarhus University

DENMARK

View details

Emma Skarsø Buhl

Aarhus University

DENMARK

View details

Ninna Aggerholm-Pedersen

Aarhus University

DENMARK

View details

Trine Tramm

Associate Professor, Consultant Pathologist

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lise Bech Jellesmark Thorsen

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Assessing Functional Outcomes and Health-Related Quality of Life After Radiation Therapy in Extremity Soft Tissue Sarcoma

Prognostic value of tumor-infiltrating lymphocytes in irradiated node-positive breast cancer patients

Local recurrence with and without a tumour-bed boost: A post-hoc analysis of the DBCG IMN2 study

The effect of coronary artery calcifications and radiotherapy on the risk of coronary artery disease in high-risk breast cancer patients in the DBCG RT-Nation cohort

Internal mammary node irradiation in 4541 node-positive breast cancer patients treated with newer systemic therapies and 3D-based radiotherapy (DBCG IMN2)

Quality assurance of internal mammary node irradiation in the DBCG IMN2 study

The clinical utility of circulating human papillomavirus across squamous cell carcinomas

Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes - a cross-sectional study

End-to-end framework for automated collection of large multicentre radiotherapy datasets demonstrated in a Danish Breast Cancer Group cohort

Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer

Collaborators (6)

Robert Zachariae

Signe Borgquist

Thomas Baad-Hansen

Emma Skarsø Buhl

Ninna Aggerholm-Pedersen

Trine Tramm

Make your next move.